Personal information

No personal information available

Activities

Collapse all

Works (24)

Transplantation for myelofibrosis patients in the ruxolitinib era: a registry study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire

Bone Marrow Transplantation
2024-07 | Journal article
DOI: 10.1038/s41409-024-02268-5
Contributors: Sara Villar; Sylvie Chevret; Xavier Poire; Magalie Joris; Patrice Chevallier; Jean-Henri Bourhis; Edouard Forcade; Sylvain Chantepie; David Beauvais; Nicole Raus et al.
Source: check_circle
Crossref

In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT

Bone Marrow Transplantation
2024-04 | Journal article
DOI: 10.1038/s41409-023-02160-8
Contributors: Meral Beksac; Diderik-Jan Eikema; Linda Koster; Cyrille Hulin; Xavier Poiré; Rose-Marie Hamladji; Tomasz Gromek; Ali Bazarbachi; Zubeyde Nur Ozkurt; Thomas Pabst et al.
Source: check_circle
Crossref

Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with hyperdiploid complex karyotype

Bone Marrow Transplantation
2024-02 | Journal article
DOI: 10.1038/s41409-023-02167-1
Contributors: Xavier Poiré; Myriam Labopin; Emmanuelle Polge; Arnold Ganser; Gérard Socié; Tobias Gedde-Dahl; Edouard Forcade; Jürgen Finke; Yves Chalandon; Claude-Eric Bulabois et al.
Source: check_circle
Crossref

Supplementary Figures S1-S16 from Product Attributes of CAR T-cell Therapy Differentially Associate with Efficacy and Toxicity in Second-line Large B-cell Lymphoma (ZUMA-7)

2024-01-25 | Preprint
DOI: 10.1158/2643-3230.25062061
Contributors: Simone Filosto; Saran Vardhanabhuti; Miguel A. Canales; Xavier Poiré; Lazaros J. Lekakis; Sven de Vos; Craig A. Portell; Zixing Wang; Christina To; Marco Schupp et al.
Source: check_circle
Crossref

Supplementary Figures S1-S16 from Product Attributes of CAR T-cell Therapy Differentially Associate with Efficacy and Toxicity in Second-line Large B-cell Lymphoma (ZUMA-7)

2024-01-25 | Preprint
DOI: 10.1158/2643-3230.25062061.v1
Contributors: Simone Filosto; Saran Vardhanabhuti; Miguel A. Canales; Xavier Poiré; Lazaros J. Lekakis; Sven de Vos; Craig A. Portell; Zixing Wang; Christina To; Marco Schupp et al.
Source: check_circle
Crossref

Data from Product Attributes of CAR T-cell Therapy Differentially Associate with Efficacy and Toxicity in Second-line Large B-cell Lymphoma (ZUMA-7)

2024-01-08 | Preprint
DOI: 10.1158/2643-3230.c.7014122
Contributors: Simone Filosto; Saran Vardhanabhuti; Miguel A. Canales; Xavier Poiré; Lazaros J. Lekakis; Sven de Vos; Craig A. Portell; Zixing Wang; Christina To; Marco Schupp et al.
Source: check_circle
Crossref

Data from Product Attributes of CAR T-cell Therapy Differentially Associate with Efficacy and Toxicity in Second-line Large B-cell Lymphoma (ZUMA-7)

2024-01-08 | Preprint
DOI: 10.1158/2643-3230.c.7014122.v1
Contributors: Simone Filosto; Saran Vardhanabhuti; Miguel A. Canales; Xavier Poiré; Lazaros J. Lekakis; Sven de Vos; Craig A. Portell; Zixing Wang; Christina To; Marco Schupp et al.
Source: check_circle
Crossref

Product Attributes of CAR T-cell Therapy Differentially Associate with Efficacy and Toxicity in Second-line Large B-cell Lymphoma (ZUMA-7)

Blood Cancer Discovery
2024-01-08 | Journal article
DOI: 10.1158/2643-3230.BCD-23-0112
Contributors: Simone Filosto; Saran Vardhanabhuti; Miguel A. Canales; Xavier Poiré; Lazaros J. Lekakis; Sven de Vos; Craig A. Portell; Zixing Wang; Christina To; Marco Schupp et al.
Source: check_circle
Crossref

Supplementary Figures S1-S16 from Product Attributes of CAR T-cell Therapy Differentially Associate with Efficacy and Toxicity in Second-line Large B-cell Lymphoma (ZUMA-7)

2024-01-08 | Preprint
DOI: 10.1158/2643-3230.24958718
Contributors: Simone Filosto; Saran Vardhanabhuti; Miguel A. Canales; Xavier Poiré; Lazaros J. Lekakis; Sven de Vos; Craig A. Portell; Zixing Wang; Christina To; Marco Schupp et al.
Source: check_circle
Crossref

Supplementary Figures S1-S16 from Product Attributes of CAR T-cell Therapy Differentially Associate with Efficacy and Toxicity in Second-line Large B-cell Lymphoma (ZUMA-7)

2024-01-08 | Preprint
DOI: 10.1158/2643-3230.24958718.v1
Contributors: Simone Filosto; Saran Vardhanabhuti; Miguel A. Canales; Xavier Poiré; Lazaros J. Lekakis; Sven de Vos; Craig A. Portell; Zixing Wang; Christina To; Marco Schupp et al.
Source: check_circle
Crossref

In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT

2023-09-22 | Preprint
DOI: 10.21203/rs.3.rs-3325630/v1
Contributors: Meral Beksac; Dirk-Jan Eikema; Linda Koster; Cyrille Hulin; Xavier Poiré; Rose-Marie Hamladji; Tomaz Gromek; Ali Bazarbachi; Zubeyde Ozkurt; Thomas Pabst et al.
Source: check_circle
Crossref

Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia with Hyperdiploid Complex Karyotype

2023-06-26 | Preprint
DOI: 10.21203/rs.3.rs-3049747/v1
Contributors: Xavier Poiré; Myriam Labopin; Emmanuelle Polge; Arnold Ganser; Gerard Socie; Tobias Gedde-Dahl; Edouard Forcade; Jürgen Finke; Yves Chalandon; Claude-Eric BULABOIS et al.
Source: check_circle
Crossref

Combining blinatumomab and donor lymphocyte infusion in B-ALL patients relapsing after allogeneic hematopoietic cell transplantation: a study of the SFGM-TC

Bone Marrow Transplantation
2023-01 | Journal article
DOI: 10.1038/s41409-022-01846-9
Contributors: Paul Chauvet; Annalisa Paviglianiti; Myriam Labopin; Hélène Labussière; Nicolas Boissel; Marie Robin; Natacha Maillard; Marie Ouachée-Chardin; Edouard Forcade; Xavier Poiré et al.
Source: check_circle
Crossref

Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP

Bone Marrow Transplantation
2022-06 | Journal article
DOI: 10.1038/s41409-021-01555-9
Contributors: Francesco Onida; Giulia Sbianchi; Aleksandar Radujkovic; Katja Sockel; Nicolaus Kröger; Jorge Sierra; Gerard Socié; Jan Cornelissen; Xavier Poiré; Luděk Raida et al.
Source: check_circle
Crossref

Combining blinatumomab and donor lymphocyte infusion in B-ALL patients relapsing after allogeneic hematopoietic cell transplantation: A study of the SFGM-TC

2022-06-22 | Preprint
DOI: 10.21203/rs.3.rs-1754921/v1
Contributors: Paul Chauvet; Annalisa Paviglianiti; Myriam Labopin; helene labussiere; Nicolas Boissel; Marie Robin; Natacha Maillard; Marie Ouachée-Chardin; Edouard Forcade; Xavier Poiré et al.
Source: check_circle
Crossref

Allogeneic hematopoietic stem cell transplantation for adult HLH: a retrospective study by the chronic malignancies and inborn errors working parties of EBMT

Bone Marrow Transplantation
2022-05 | Journal article
DOI: 10.1038/s41409-022-01634-5
Contributors: Rafal Machowicz; Felipe Suarez; Wieslaw Wiktor-Jedrzejczak; Diderik-Jan Eikema; Liesbeth C. de Wreede; Henric-Jan Blok; Cecilia Isaksson; Hermann Einsele; Xavier Poiré; Suzanne van Dorp et al.
Source: check_circle
Crossref

Impact of donor-derived CD34 + infused cell dose on outcomes of patients undergoing allo-HCT following reduced intensity regimen for myelofibrosis: a study from the Chronic Malignancies Working Party of the EBMT

Bone Marrow Transplantation
2022-02 | Journal article
DOI: 10.1038/s41409-021-01540-2
Contributors: Tomasz Czerw; Simona Iacobelli; Vittoria Malpassuti; Linda Koster; Nicolaus Kröger; Marie Robin; Johan Maertens; Patrice Chevallier; Emma Watz; Xavier Poiré et al.
Source: check_circle
Crossref

Sequential administration of low dose 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) in relapse after allogeneic stem cell transplantation (SCT): a prospective study from the Belgian Hematology Society (BHS)

Bone Marrow Transplantation
2022-01 | Journal article
DOI: 10.1038/s41409-021-01464-x
Contributors: Xavier Poiré; Carlos Graux; Aurélie Ory; Julie Herman; Frédéric Baron; Hélène Schoemans; Philippe Lewalle; Ann De Becker; Dries Deeren; Zwi Berneman et al.
Source: check_circle
Crossref

Outcomes following second allogeneic haematopoietic cell transplantation in patients with myelofibrosis: a retrospective study of the Chronic Malignancies Working Party of EBMT

Bone Marrow Transplantation
2021-08-06 | Journal article
DOI: 10.1038/s41409-021-01271-4
Contributors: Mitja Nabergoj; Katya Mauff; Marie Robin; Nicolaus Kröger; Emanuele Angelucci; Xavier Poiré; Jakob Passweg; Aleksandar Radujkovic; Uwe Platzbecker; Stephen Robinson et al.
Source: check_circle
Crossref

Risk factors for a severe form of COVID‐19 after allogeneic haematopoietic stem cell transplantation: a Société Francophone de Greffe de Moelle et de Thérapie cellulaire (SFGM‐TC) multicentre cohort study

British Journal of Haematology
2021-03 | Journal article
DOI: 10.1111/bjh.17260
Contributors: Alienor Xhaard; Constance Xhaard; Maud D’Aveni; Helene Salvator; Marie‐Laure Chabi; Ana Berceanu; Tereza Coman; Yves Beguin; Yves Chalandon; Xavier Poiré et al.
Source: check_circle
Crossref

Haploidentical transplantation and posttransplant cyclophosphamide for treating aplastic anemia patients: a report from the EBMT Severe Aplastic Anemia Working Party

Bone Marrow Transplantation
2020-06-16 | Journal article
DOI: 10.1038/s41409-019-0773-0
Contributors: Pedro H. Prata; Dirk-Jan Eikema; Boris Afansyev; Paul Bosman; Frans Smiers; José L. Diez-Martin; Celso Arrais-Rodrigues; Yener Koc; Xavier Poiré; Anne Sirvent et al.
Source: check_circle
Crossref

The impact of concomitant cytogenetic abnormalities on acute myeloid leukemia with monosomy 7 or deletion 7q after HLA‐matched allogeneic stem cell transplantation

American Journal of Hematology
2020-03 | Journal article
DOI: 10.1002/ajh.25714
Contributors: Xavier Poiré; Myriam Labopin; Emmanuelle Polge; Liisa Volin; Jürgen Finke; Arnold Ganser; Didier Blaise; Ibrahim Yakoub‐Agha; Dietrich Beelen; Edouard Forcade et al.
Source: check_circle
Crossref

Providing both autologous and allogeneic hematopoietic stem cell transplants (HSCT) may have a stronger impact on the outcome of autologous HSCT in adult patients than activity levels or implementation of JACIE at Belgian transplant centres

Bone Marrow Transplantation
2019-09-29 | Journal article
DOI: 10.1038/s41409-019-0458-8
Contributors: Hélène A. Poirel; Marijke Vanspauwen; Gilles Macq; Anke De Geyndt; Johan Maertens; Evelyne Willems; Dominik Selleslag; Xavier Poiré; Koen Theunissen; Carlos Graux et al.
Source: check_circle
Crossref

Hematopoietic stem cell transplantation for adult patients with isolated NPM1 mutated acute myeloid leukemia in first remission

American Journal of Hematology
2019-02 | Journal article
DOI: 10.1002/ajh.25355
Contributors: Xavier Poiré; Myriam Labopin; Emmanuelle Polge; Didier Blaise; Patrice Chevallier; Johan Maertens; Eric Deconinck; Edouard Forcade; Alessandro Rambaldi; Gabriela M. Baerlocher et al.
Source: check_circle
Crossref

Peer review (7 reviews for 1 publication/grant)

Review activity for Bone marrow transplantation (7)
How many people are using ORCID?